Published in AIDS Weekly, July 8th, 2002
The team used short forms of RNA - ribonucleic acid - that turn off genes vital for the production of proteins used by the virus to enter and infect cells. RNA carries the blueprint for constructing proteins.
"If many obstacles can be surmounted this could be a basis for intervention in HIV treatment," said Dr. Phillip A. Sharp, who led the research.
The work was conducted in the laboratory, and problems to be solved include...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.